Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro
about
Extensive Central Nervous System Cryptococcal Disease Presenting as Immune Reconstitution Syndrome in a Patient with Advanced HIV: Report of a Case and Review of Management Dilemmas and StrategiesReactive oxygen species-inducing antifungal agents and their activity against fungal biofilmsFatty acid synthase impacts the pathobiology of Candida parapsilosis in vitro and during mammalian infectionSusceptibility of Pneumocystis to echinocandins in suspension and biofilm culturesAntibody-mediated immobilization of Cryptococcus neoformans promotes biofilm formation.Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis.Regulatory circuitry governing fungal development, drug resistance, and disease.Saccharomyces cerevisiae biofilm tolerance towards systemic antifungals depends on growth phaseAntibody-guided alpha radiation effectively damages fungal biofilmsBiofilm formation by Cryptococcus neoformans under distinct environmental conditions.Synthesis and assembly of fungal melaninImpact of melanin on microbial virulence and clinical resistance to antimicrobial compounds.Cryptococcus neoformans cells in biofilms are less susceptible than planktonic cells to antimicrobial molecules produced by the innate immune system.In vitro Paracoccidioides brasiliensis biofilm and gene expression of adhesins and hydrolytic enzymes.In Vitro Activity of Miltefosine against Candida albicans under Planktonic and Biofilm Growth Conditions and In Vivo Efficacy in a Murine Model of Oral CandidiasisFungal biofilm resistance.Cryptococcus neoformans biofilm formation depends on surface support and carbon source and reduces fungal cell susceptibility to heat, cold, and UV lightTargeted gene deletion in Candida parapsilosis demonstrates the role of secreted lipase in virulence.Fungal Biofilms: In Vivo Models for Discovery of Anti-Biofilm DrugsThe Anti-helminthic Compound Mebendazole Has Multiple Antifungal Effects against Cryptococcus neoformans.Magnesium Ion Acts as a Signal for Capsule Induction in Cryptococcus neoformans.Sustained Nitric Oxide-Releasing Nanoparticles Induce Cell Death in Candida albicans Yeast and Hyphal Cells, Preventing Biofilm Formation In Vitro and in a Rodent Central Venous Catheter ModelDihydroxynaphthalene-based mimicry of fungal melanogenesis for multifunctional coatings.Methamphetamine enhances Cryptococcus neoformans pulmonary infection and dissemination to the brain.Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistanceA simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing.The use of chitosan to damage Cryptococcus neoformans biofilms.Our current understanding of fungal biofilms.Proteomic profile of Cryptococcus neoformans biofilm reveals changes in metabolic processes.Variability of phenotypic traits in Cryptococcus varieties and species and the resulting implications for pathogenesis.Mechanisms of cryptococcal virulence and persistence.Fungal Biofilms: Relevance in the Setting of Human Disease.Candida species: new insights into biofilm formation.Methods for obtaining reliable and reproducible results in studies of Candida biofilms formed in vitro.Impact of Resistance to Fluconazole on Virulence and Morphological Aspects of Cryptococcus neoformans and Cryptococcus gattii Isolates.The Extracellular Matrix of Fungal Biofilms.Virulence of Cryptococcus sp. Biofilms In Vitro and In Vivo using Galleria mellonella as an Alternative ModelAn extracellular matrix glues together the aerial-grown hyphae of Aspergillus fumigatus.EDTA inhibits biofilm formation, extracellular vesicular secretion, and shedding of the capsular polysaccharide glucuronoxylomannan by Cryptococcus neoformans.Characterization of phenotypic switching in Cryptococcus neoformans biofilms.
P2860
Q26852378-63E5CAED-EF71-41DB-945F-31AFDAD0B098Q26861656-42401891-B21A-4206-89A3-5318018B2069Q28472288-C433EFDF-FD1A-477F-A415-A0FCEBA6B9FEQ28477349-69856252-5308-40FD-95CF-603878C3A1F2Q30487314-B95C0D5A-7E73-4832-825E-4BA44F4201EFQ33790656-27244AB1-ABAF-4BB6-B47A-607D05CFD7F5Q34190284-81AD986E-94C3-4399-895A-7792911E7A46Q34643153-02B90E95-6E4B-42CA-9AF9-C32B23F2C5C0Q34680558-6C85A3D7-6330-45EA-98BC-285138074B00Q34781743-CBB6490C-FF56-4CB4-93C8-31F3E7DF8443Q35054788-EC0317F5-C298-474A-8F4D-4E3715E21B22Q35127872-DECA164F-5796-46C7-89D9-1306B3D33164Q35217511-7CD8576E-739C-45DE-A16B-F8999800BAAFQ35657432-FB91F3E5-C28D-48E9-A207-9B9A604198B6Q35791192-8B30D2EF-4606-4CDA-AF87-E934E9ACA6F0Q35821475-643F2E88-B7AF-48A0-9E6C-96F4B2CB1914Q35913297-C587124A-9BE8-4315-A966-51644D5DAB91Q35987590-18D32F5D-6277-4ACC-87C7-795CE9701594Q36089061-C924ED60-746C-4F10-B404-FE682226039FQ36344094-717A388F-0F0C-4298-BB83-3259006B94F6Q36686273-CA4E1FC2-F0FA-46E0-BB5E-BCA5FB4E7E47Q36730043-E464843B-AD86-49AF-9CE2-FF211913DCAAQ36809540-56DAD4E1-9F88-4C08-9048-F3119646FFBFQ37074706-3A461BFC-98B5-4E16-8076-D566C5514DECQ37122826-49EF0A1F-FD75-4933-B407-818D1308EC51Q37340616-B6ED5C69-0273-44D3-AF13-FC91683FEE59Q37438897-8F3D3399-FF79-4C21-9312-835B42744C3FQ37622959-9716F86A-596F-457F-99D0-20731C814027Q37714187-4856C514-50E3-45E6-B9EC-105E0A5D88F9Q37742176-C86A11CD-9395-4FF6-A37B-C15107E36735Q37781066-9764EFC3-FC37-451E-B426-BEC50F2036CEQ37887512-D79E4ED5-6E1B-4692-9558-578125F7D36FQ38019018-EFA456E5-B2F0-4743-B1CE-0E03D569F59CQ38109647-D2DD5545-6B1B-4EF8-99E1-82435E63A6CAQ38467366-0607E47A-B40B-4E8F-9EA9-A93660B5D343Q38856993-BA8A0C4D-821C-483A-AB0E-3BFDD2DD9661Q38858709-B84C0967-948C-4A65-ADAE-3BB0963EBB8DQ40232088-2BF2DD1A-533C-4A95-B8A2-F7C655D83991Q41588074-3924B75B-4DB4-456A-8480-F625E386EF93Q43077543-D89E3981-DC64-4A22-BFCA-CA60F3DAB8CC
P2860
Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro
@ast
Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro
@en
Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro
@nl
type
label
Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro
@ast
Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro
@en
Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro
@nl
prefLabel
Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro
@ast
Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro
@en
Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro
@nl
P2860
P1476
Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro
@en
P2093
Luis R Martinez
P2860
P304
P356
10.1128/AAC.50.3.1021-1033.2006
P407
P577
2006-03-01T00:00:00Z